Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Redfield

Showing results (201-210 of 336) with videos related to

Pageof 34
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinicsAnthony Amoroso, Martine Etienne-Mesubi, Anthony Edozien, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and immunogenicity of multiple conventional immunizations administered during early HIV infectionJ L Rhoads, D L Birx, D C Wright, et al.
New York State Journal of Medicine|May 1, 1987
Demography of HIV infections among civilian applicants for military service in four counties in New York CityD S Burke, J F Brundage, W Bernier, et al.
Transplantation|October 19, 2018
Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney TransplantationSandesh Parajuli, Robert R Redfield, Neetika Garg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2003
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1A Heredia, A Amoroso, C Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1T C VanCott, F R Bethke, V R Polonis, et al.
Plos One|August 18, 2017
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized miceSandra Medina-Moreno, Thomas C Dowling, Juan C Zapata, et al.
AIDS (London, England)|October 14, 2017
Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan AfricaKristen A Stafford, Laurence S Magder, Laura L Hungerford, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo StudiesOlga S Latinovic, Sandra Medina-Moreno, Kate Schneider, et al.
Transplantation|July 12, 2018
Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific AntibodiesSandesh Parajuli, Sayee Alagusundaramoorthy, Fahad Aziz, et al.
Pageof 34

Showing results (201-210 of 336) with videos related to

Sort By:
Pageof 34
Journal of Acquired Immune Deficiency Syndromes (1999)|February 21, 2012
Treatment outcomes of recommended first-line antiretroviral regimens in resource-limited clinicsAnthony Amoroso, Martine Etienne-Mesubi, Anthony Edozien, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and immunogenicity of multiple conventional immunizations administered during early HIV infectionJ L Rhoads, D L Birx, D C Wright, et al.
New York State Journal of Medicine|May 1, 1987
Demography of HIV infections among civilian applicants for military service in four counties in New York CityD S Burke, J F Brundage, W Bernier, et al.
Transplantation|October 19, 2018
Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney TransplantationSandesh Parajuli, Robert R Redfield, Neetika Garg, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2003
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1A Heredia, A Amoroso, C Davis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1T C VanCott, F R Bethke, V R Polonis, et al.
Plos One|August 18, 2017
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized miceSandra Medina-Moreno, Thomas C Dowling, Juan C Zapata, et al.
AIDS (London, England)|October 14, 2017
Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan AfricaKristen A Stafford, Laurence S Magder, Laura L Hungerford, et al.
AIDS Research and Human Retroviruses|June 11, 2015
Full Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo StudiesOlga S Latinovic, Sandra Medina-Moreno, Kate Schneider, et al.
Transplantation|July 12, 2018
Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific AntibodiesSandesh Parajuli, Sayee Alagusundaramoorthy, Fahad Aziz, et al.
Pageof 34